Sensitivity of FNA cytology, NCB, and combined FNA/NCB in 129 malignant cases and 12 benign cases
| Diagnostic sensitivity (%) | |||
|---|---|---|---|
| Biopsy site | FNA | NCB | Combined |
| FNA, fine needle aspiration; NCB, needle core biopsy, NOS, not otherwise specified. | |||
| Malignant | |||
| Liver | |||
| Metastatic malignancy (n=87) | 75 (86.2) | 71 (82.8) | 77 (88.5) |
| Hepatocellular carcinoma (n=9) | 9 (100) | 8 (88.9) | 9 (100) |
| Pancreas (n=14) | 11 (78.6) | 10 (71.4) | 13 (92.9) |
| Kidney (n=5) | 5 (100) | 3 (60) | 5 (100) |
| Adrenal (n=2) | 0 (0) | 1 (50) | 1 (50) |
| Retroperitoneum (n=3) | 2 (66.7) | 3 (100) | 3 (100) |
| Abdomen/pelvis, NOS (n=9) | 9 (100) | 8 (88.9) | 9 (100) |
| Total (n=129) | 111 (86) | 104 (80.6) | 117 (90.7) |
| Benign | |||
| Liver (n=9) | 9 (100) | 8 (88.9) | 9 (100) |
| Pancreas (n=3) | 2 (66.7) | 1 (33.3) | 2 (66.7) |
| Total (n=12) | 11 (91.7) | 9 (75) | 11 (91.7) |